These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy. Mazokopakis EE, Starakis IK, Papadomanolaki MG, Batistakis AG, Papadakis JA. Curr Med Res Opin; 2006 Jul; 22(7):1369-73. PubMed ID: 16834835 [Abstract] [Full Text] [Related]
4. [The risk factors and bone mineral density in women on long-term levothyroxine treatment]. López Alvarez MB, Hawkins F, Rigopoulou D, Martínez G, Jodar E, Estenoz J, Ortuño B, Arnaiz F. Med Clin (Barc); 1999 Jan 30; 112(3):85-9. PubMed ID: 10074614 [Abstract] [Full Text] [Related]
6. The long term effect of levothyroxine on bone mineral density in patients with well differentiated thyroid carcinoma after treatment. Eftekhari M, Asadollahi A, Beiki D, Izadyar S, Gholamrezanezhad A, Assadi M, Fard-Esfahani A, Fallahi B, Takavar A, Saghari M. Hell J Nucl Med; 2008 Jan 30; 11(3):160-3. PubMed ID: 19081859 [Abstract] [Full Text] [Related]
7. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine. Karner I, Hrgović Z, Sijanović S, Buković D, Klobucar A, Usadel KH, Fassbender WJ. Eur J Med Res; 2005 Nov 16; 10(11):480-8. PubMed ID: 16354602 [Abstract] [Full Text] [Related]
8. [Bone tissue mineral density in patients with thyroid gland cancer on levothyroxine natrium therapy]. Khmara IM, Tolkachev IuV. Klin Med (Mosk); 2005 Nov 16; 83(10):61-5. PubMed ID: 16320850 [Abstract] [Full Text] [Related]
11. Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study. Bauer M, Fairbanks L, Berghöfer A, Hierholzer J, Bschor T, Baethge C, Rasgon N, Sasse J, Whybrow PC. J Affect Disord; 2004 Dec 16; 83(2-3):183-90. PubMed ID: 15555712 [Abstract] [Full Text] [Related]
13. A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. Diamond T, Nery L, Hales I. J Clin Endocrinol Metab; 1991 Jun 16; 72(6):1184-8. PubMed ID: 2026740 [Abstract] [Full Text] [Related]
15. [Bone mineral density in patients on long-term therapy with levothyroxine]. Korsić M, Cvijetić S, Dekanić-Ozegović D, Bolanća S, Kozić B. Lijec Vjesn; 1998 May 16; 120(5):103-5. PubMed ID: 9748785 [Abstract] [Full Text] [Related]
16. A comparative study of bone mineral density between premenopausal women with hyperthyroidism and healthy premenopausal women. Boonya-Ussadorn T, Punkaew B, Sriassawaamorn N. J Med Assoc Thai; 2010 Nov 16; 93 Suppl 6():S1-5. PubMed ID: 21284134 [Abstract] [Full Text] [Related]
17. Four years follow-up of bone mineral density change in premenopausal women with systemic lupus erythematosus. Uaratanawong S, Deesomchok U, Hiransuttikul N, Uaratanawong S. J Med Assoc Thai; 2004 Nov 16; 87(11):1374-9. PubMed ID: 15825716 [Abstract] [Full Text] [Related]